Biotech Startups

Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures. It serves healthcare professionals in the U.S. and developing regions, and is based in New Orleans, Louisiana.

2 investors

BioCorteX develops personalized therapeutics using a microbiome knowledge graph and proprietary biology emulation platform to tailor drug treatments for diverse populations. The company aims to improve treatment efficacy across different communities by accounting for individual microbiome variations in drug development.

2 investors

BioCsol develops engineered formulations combining active compounds with complementary mechanisms of action for agricultural use, delivering biodegradable solutions that protect soil health while preventing resistance.

2 investors

BioEclipse Therapeutics is a clinical-stage oncology company developing immuno-oncology therapeutics using a proprietary platform that targets the tumor microenvironment through engineered immune cell therapies. The company's approach combines multiple mechanisms of action to eradicate cancer cells and generate durable immune responses against relapse and recurrence.

2 investors

BioFeyn is a life sciences company that applies biomedical nanoencapsulation technology (its "Feyn" delivery mechanism) to feed ingredients, improving nutrient absorption and bioavailability in animals. It focuses on aquaculture and agriculture, particularly salmon farming, serving farmers and feed suppliers while reducing waste and environmental impact.</parameter> <parameter name="founders">[{"full_name": "Timothy Bouley", "title": "CEO, Founder"}, {"full_name": "Marie-Christine Imbert", "title": "CSO, Founder"}]

2 investors

Bioherent develops photonic biosensing technology for ultra-sensitive diagnostic detection of allergic and immunological responses. The company serves healthcare providers and patients needing faster, more accessible allergy and immunology diagnostics through proprietary light-based engineering.

2 investors

BioHeuris develops biotech tools using gene editing to improve weed control efficiency and crop production for farmers. The company works with seed companies, growers, and researchers to deploy genome-edited crop traits across soybean, cotton, and sorghum.

2 investors

BioIntelligence Technologies builds an analytics platform that performs in-situ, simultaneous measurement of products, nutrients and metabolic intermediates with real-time analysis to optimize bioprocess profitability. It serves biotech companies in the transformation industry, targeting pharmaceutical and greener-chemical production.

2 investors

BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.

2 investors

BiomeBank develops microbiome-based therapies aimed at restoring the gut microbial ecosystem, with a focus on conditions such as inflammatory bowel disease and Clostridioides difficile infection. The company operates a cGMP manufacturing facility in Adelaide and works with academic and hospital research partners on drug discovery and clinical development.

2 investors

Biomodal develops genomic and epigenomic sequencing technologies for life scientists and clinical researchers, enabling simultaneous analysis of genetic data and modified cytosine bases from a single DNA sample. The company's tools integrate pre- and post-sequencing workflows to capture both canonical and modified bases in the genome.

2 investors

Biomoneta develops air decontamination devices that use ZeBox technology to eliminate airborne pathogens and provide medical-grade sterility without ozone or harmful radiation. The company offers medical-grade and consumer-grade air purification systems for hospitals, healthcare facilities, and homes.

2 investors

Biophilica is a biotechnology company that develops Treekind, a 100% biobased, plastic-free material for the fashion, footwear, packaging, furniture, homeware and automotive industries. The material is certified biobased and vegan, offered as an alternative to petrochemical-based products.

2 investors

BioRaptor provides a bioprocess data management platform that stores and analyzes biological metrics to help biotechnology teams move from trial-and-error to optimized experimentation. The platform serves bioprocessing teams in R&D, scale-up, and production by making scientific data connected, contextualized, and actionable.

2 investors

BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration. The company manufactures and sells biomimetic tissue repair and regeneration products for clinical use globally.

2 investors

Biorelate provides AI-led biomedical data curation for the biopharma industry, extracting cause-and-effect evidence from scientific literature to support drug discovery. It serves biotechs, pharmaceutical companies, data scientists, and computational biologists through its Galactic AI platform.

2 investors

BioRock Ventures is a seed-stage venture capital fund that invests in private life science startups developing novel FDA-regulated therapeutic drugs across all disease areas and modalities. It makes angel, seed, and Series A investments through to pre-IPO/M&A, based in the San Francisco Bay Area.

2 investors

Bioskryb provides genomic sequencing and single-cell analysis solutions for biopharmaceutical companies and clinical researchers, enabling them to characterize circulating tumor cells, identify biomarkers, and support drug development across oncology, neurology, and cell/gene editing applications.

2 investors

Biosphere develops bioreactors and biomanufacturing systems to modernize industrial production of chemicals, materials, foods, and pharmaceuticals using engineered biology and clean energy. The company addresses the production bottleneck in the $100b bioproducts industry by moving beyond decades-old reactor designs.

2 investors

EcoBiotaX develops a microbial ecology platform that uses AI (its ecoSat computational platform) and biological methods to discover and construct natural bacterial communities for specific biological functions. It targets applications in health, food, agriculture, and climate.

2 investors

Biotheryx is a clinical-stage biopharmaceutical company developing first-in-class targeted protein degraders, including molecular glues and bifunctional degraders, with an initial focus on cancer and inflammatory disease. Its drug discovery work is built on modulating Cereblon and its proprietary PRODEGY platform.

2 investors

Biotts develops proprietary drug products and transdermal delivery systems for pharmaceutical applications, with a focus on improving patient quality of life.

2 investors

biotx.ai maps how genes causally shape human biology by systematically testing every human gene across tissues using large-scale Mendelian randomization, colocalization, and causal AI. This generates high-confidence causal links between genes, diseases, and biomarkers for drug target discovery.

2 investors

BIOVECTRA is a contract development and manufacturing organization (CDMO) with research and development capabilities in biologics process development, complex chemistry, and analytical development. Its work spans recombinant proteins, viral vectors, mRNA vaccines, and pharmaceutical process development for the biotech and pharmaceutical industries.

2 investors